BCAX
BCAX
NASDAQ · Biotechnology

Bicara Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$22.58
-0.51 (-2.21%)
As of May 9, 9:38 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 16 80%
Hold 4 20%
Sell 0 0%
Price Target
Analyst Price Target -35.8% upside
Low Target $9.75
Average Target $14.50
High Target $19.19
Current Price $22.58
Current
$22.58
Target
$14.50
$9.75 $14.50 avg $19.19
Scenario Analysis
Bear Case
$9.75
-56.8%
Low target
Base Case
$14.50
-35.8%
Avg target
Bull Case
$19.19
+-15.0%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$24.25
-6.9% from high
52-Week Low
$7.80
+189.5% from low
Target vs 52W High
$14.50
-40.2% vs high
Next Earnings Report
May 19, 2026
8d
until earnings
EPS Est: $-0.66
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%